Delivery Order SPE2DB20D7066-SPE2DB25FC3NM
- Not listed
- The Defense Logistics Agency awarded a $108.8K delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract reflects firm fixed pricing and carries an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $44,205.78. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,421.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this...
- The Defense Logistics Agency awarded a $25,655.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Arimidex 1 mg tablets (30-count units) valued at $3,417.58. This firm fixed price delivery order is scheduled for completion by August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,690.72, is for the delivery of 4,568,092,832 tablets of the prescription medication Arimidex (1 mg). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,925.36 contract is for the delivery of 4,567,937,962 units of the pharmaceutical product Arimidex 1 mg tablets. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.66 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging). The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is issued as a child order under the company's larger...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB25FW62L, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,118.58 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,802.19 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $4,802.19 and an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3NMDelivery Order
The Defense Logistics Agency awarded a $11,784.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count supply) with a completion date of June 2, 2025. This non-competitive delivery order was issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling military healthcare supply needs through AmerisourceBergen's comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains extensive federal contract portfolio supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. The underlying IDC demonstrates the company's capability to serve as a prime vendor for defense medical logistics on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 5/30/25 |